KY Biotechnology & Medical Research

Adagene Inc (ADAG)

Track

Track

Adagene Inc. recorded thirteen insider trading transactions recently. Executives, including the CEO and CFO, initiated buys totaling approximately $162,244. Conversely, officers filed proposed sales amounting to $1,034,900. These activities occurred amid a 30.7% decline in stock value over ninety days, despite no immediate updates regarding the latest earnings report.
Ticker: ADAG Exchange: NMS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Adagene Inc. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Tam Man Kin Chief Financial Officer Executive Director
Transaction date
Purchase
Price
123.17
Quantity 84,068 +8.7%
Value US$4,115,978
Luo Peter Chief Executive Officer Executive Director
Transaction date
Purchase
Price
407.26
Quantity 91,182 +30.8%
Value US$3,982,487
Adagene Inc. Officer Officer
Transaction date
Proposed sale
Price
478.85
Quantity 40,725
Value US$1,805,850
Adagene Inc. Officer Officer
Transaction date
Proposed sale
Price
3.95
Quantity 40,000
Value US$158,000
GU CHUNFANG Officer Officer
Transaction date
Proposed sale
Price
3.95
Quantity 11,000
Value US$43,450
Adagene Inc. Officer Officer
Transaction date
Proposed sale
Price
3.95
Quantity 40,000
Value US$158,000
GU CHUNFANG Officer Officer
Transaction date
Proposed sale
Price
3.95
Quantity 40,000
Value US$158,000
Adagene Inc. Officer Officer
Transaction date
Proposed sale
Price
3.95
Quantity 40,000
Value US$158,000
GU CHUNFANG Officer Officer
Transaction date
Proposed sale
Price
3.95
Quantity 40,000
Value US$158,000
GU CHUNFANG Officer Officer
Transaction date
Proposed sale
Price
3.95
Quantity 40,000
Value US$158,000
0.8
DO CUONG V Non-Executive Director
Transaction date
Purchase
Price
3.75
Quantity 2,000 +inf%
Value US$7,500
Luo Peter Chief Executive Officer Executive Director
Transaction date
Purchase
Price
3.65
Quantity 279 +0.4%
Value US$1,018
Luo Peter Chief Executive Officer Executive Director
Transaction date
Purchase
Price
3.65
Quantity 22,966 +51.0%
Value US$83,746
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-09-25 2026-09-23 B Purchase
Tam Man Kin

Chief Financial Officer

Executive Director
84,068 +8.7%
123.17
US$4,115,978 		84,068 +8.7% 123.17 US$4,115,978
2026-09-17 2026-09-16 B Purchase
Luo Peter

Chief Executive Officer

Executive Director
91,182 +30.8%
407.26
US$3,982,487 		91,182 +30.8% 407.26 US$3,982,487
2026-08-20 2026-08-26 PrS Proposed sale
Adagene Inc.

Officer

Officer
40,725
478.85
US$1,805,850 		40,725 478.85 US$1,805,850
2026-08-20 2026-08-25 PrS Proposed sale
Adagene Inc.

Officer

Officer
40,000
3.95
US$158,000 		40,000 3.95 US$158,000
2026-08-19 2026-08-25 PrS Proposed sale
GU CHUNFANG

Officer

Officer
11,000
3.95
US$43,450 		11,000 3.95 US$43,450
2026-08-20 2026-08-24 PrS Proposed sale
Adagene Inc.

Officer

Officer
40,000
3.95
US$158,000 		40,000 3.95 US$158,000
2026-08-19 2026-08-24 PrS Proposed sale
GU CHUNFANG

Officer

Officer
40,000
3.95
US$158,000 		40,000 3.95 US$158,000
2026-08-20 2026-08-21 PrS Proposed sale
Adagene Inc.

Officer

Officer
40,000
3.95
US$158,000 		40,000 3.95 US$158,000
2026-08-19 2026-08-21 PrS Proposed sale
GU CHUNFANG

Officer

Officer
40,000
3.95
US$158,000 		40,000 3.95 US$158,000
2026-08-19 2026-08-20 PrS Proposed sale
GU CHUNFANG

Officer

Officer
40,000
3.95
US$158,000 		40,000 3.95 US$158,000
2026-08-18 2026-08-14 B Purchase
0.8
DO CUONG V
Non-Executive Director
2,000 +inf%
3.75
US$7,500 		2,000 +inf% 3.75 US$7,500
2026-08-06 2026-08-05 B Purchase
Luo Peter

Chief Executive Officer

Executive Director
279 +0.4%
3.65
US$1,018 		279 +0.4% 3.65 US$1,018
2026-08-06 2026-08-04 B Purchase
Luo Peter

Chief Executive Officer

Executive Director
22,966 +51.0%
3.65
US$83,746 		22,966 +51.0% 3.65 US$83,746
Explore more

More insider trading research around Adagene Inc

More insider trades in KY
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity